tradingkey.logo
tradingkey.logo
検索

GeneDx Holdings Corp

WGS
ウォッチリストに追加
39.920USD
+0.980+2.52%
取引時間 ET15分遅れの株価
1.18B時価総額
損失額直近12ヶ月PER

GeneDx Holdings Corp

39.920
+0.980+2.52%

詳細情報 GeneDx Holdings Corp 企業名

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corpの企業情報

企業コードWGS
会社名GeneDx Holdings Corp
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)
従業員数1000
証券種類Ordinary Share
決算期末Sep 04
本社所在地333 Ludlow Street
都市STAMFORD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号06902
電話番号18887291206
ウェブサイトhttps://sema4.com/
企業コードWGS
上場日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)

GeneDx Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
4.44M
+99.55%
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
34.94K
+0.28%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
4.44M
+99.55%
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
34.94K
+0.28%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Patients with third party insurance
345.24M
80.75%
Institutional customers
70.07M
16.39%
Other
10.87M
2.54%
Self pay patients
1.36M
0.32%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Patients with third party insurance
345.24M
80.75%
Institutional customers
70.07M
16.39%
Other
10.87M
2.54%
Self pay patients
1.36M
0.32%

株主

更新時刻: 14 hours ago
更新時刻: 14 hours ago
株主統計
種類
株主統計
株主統計
比率
Meister (Keith A)
14.95%
Corvex Management LP
14.93%
Icahn School of Medicine at Mount Sinai
4.63%
OPKO Health Inc
4.62%
Westfield Capital Management Company, L.P.
4.61%
他の
56.27%
株主統計
株主統計
比率
Meister (Keith A)
14.95%
Corvex Management LP
14.93%
Icahn School of Medicine at Mount Sinai
4.63%
OPKO Health Inc
4.62%
Westfield Capital Management Company, L.P.
4.61%
他の
56.27%
種類
株主統計
比率
Investment Advisor/Hedge Fund
35.13%
Investment Advisor
33.09%
Hedge Fund
32.91%
Corporation
10.37%
Research Firm
6.51%
Individual Investor
1.81%
Pension Fund
0.40%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.23%

機関投資家保有株

更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
456
30.28M
113.16%
--
2026Q1
549
32.98M
111.70%
+333.95K
2025Q4
500
30.62M
105.95%
-3.52M
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Corvex Management LP
3.06M
10.44%
--
--
Dec 31, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.69%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.68%
-800.83K
-36.88%
Nov 20, 2024
Westfield Capital Management Company, L.P.
1.02M
3.48%
+474.17K
+87.15%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.34M
4.58%
+25.70K
+1.95%
Dec 31, 2025
ARK Investment Management LLC
604.56K
2.06%
+157.58K
+35.25%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.02M
3.48%
+17.80K
+1.78%
Dec 31, 2025
Summit Partners Public Asset Management, LLC
920.59K
3.14%
+97.02K
+11.78%
Dec 31, 2025
Oracle Investment Management, Inc.
884.65K
3.02%
-5.30K
-0.60%
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
詳細を見る
Global X Genomics & Biotechnology ETF
比率3.84%
Franklin Genomic Advancements ETF
比率3.47%
Clough Hedged Equity ETF
比率2.89%
Clough Select Equity ETF
比率2.65%
State Street SPDR S&P Health Care Services ETF
比率2.27%
Harbor Health Care ETF
比率1.85%
Innovator IBD Breakout Opportunities ETF
比率1.52%
ARK Genomic Revolution ETF
比率1.29%
Main Thematic Innovation ETF
比率1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
比率1.18%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
日付
配当落ち日
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI